Skip to main content
logo
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.775
-0.075 (-4.05%)
Aug 28, 2026, 2:24 PM EDT - Market open

Gain Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7712457493765
Market Cap Growth
12.24%116.16%16.03%32.75%-42.34%-
Enterprise Value
6511646381325
Last Close Price
1.853.222.163.273.135.43

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---894.85280.42481.65
PB Ratio
7.106.677.813.931.971.85
P/TBV Ratio
6.916.717.953.991.991.86

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---691.9996.63186.53

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.040.090.080.070.05
Net Debt / Equity Ratio
-1.10-1.08-1.33-1.25-1.10-1.01
Net Debt / EBITDA Ratio
0.651.080.480.711.172.55
Net Debt / FCF Ratio
0.661.090.520.841.412.83
Asset Turnover
---0.000.000.01
Quick Ratio
4.116.462.853.444.9314.53
Current Ratio
4.366.632.973.595.1114.78
Return on Equity (ROE)
-268.30%-155.66%-204.95%-141.57%-65.52%-67.73%
Return on Assets (ROA)
-95.51%-67.01%-82.80%-65.14%-35.24%-35.60%
Return on Capital Employed (ROCE)
-161.00%-96.20%-247.90%-162.90%-89.10%-38.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-25.95%-16.28%-35.63%-45.10%-47.29%-21.53%
FCF Yield
-24.47%-14.91%-32.98%-38.24%-39.82%-19.32%
Buyback Yield / Dilution
-39.34%-44.08%-75.86%-9.49%-16.90%-279.11%
SEC Filings: 10-K · 10-Q